---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-017882"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2025-02-11T23:59:59+00:00"
generated_at: "2026-05-26T23:29:01.442596+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Revelation Biosciences posts updated corporate presentation; no new specific data in filing

## Summary
- Corporate presentation dated February 10, 2025 made available on company website; content not summarized in the 8-K.
- Investors must access the company's investor relations page to view the presentation; no material updates disclosed in the filing.
- No changes to financial outlook, pipeline, or guidance were announced in this Form 8-K.

## SEC filing metadata
- accession: 0000950170-25-017882
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2025-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017025017882/0000950170-25-017882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017025017882/revb-20250210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-017882
- JSON: https://secwatch.observer/filing/0000950170-25-017882.json
- Plain text: https://secwatch.observer/filing/0000950170-25-017882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.